The TIM3/Gal9 Signaling Pathway: An Emerging Target for Cancer Immunotherapy

By Sashi Kandel, P. Adhikary, Guangfu Li, K. Cheng. 2021

Subfields: Cancer Research, Immunology, Oncology

Citations in the corpus

• Impact of T Cell Exhaustion and Stroma Senescence on Tumor Cell Biology and Clinical Outcome of Head and Neck Squamous Cell Carcinomas (2024, unknown): “Similarly, TIM-3, which is highly expressed in tumor-infiltrating lymphocytes, suppresses anti-tumor immunity through its interaction with Galectin 9 in various cancers [16].”